Research Institute

    Hyo-Jong Research Institute

    Hyo : 曉 (Dawn), Jong : 鐘 (Bell)

    Opening a new era by ringing the bell

    종근당 연구소 사진

    the realization of
    a disease-free human society

    Since the foundation, Chong Kun Dang has been pursuing a disease-free society
    by developing excellent medicines.Cognizant of the importance of drug discovery, Chong Kun Dang was the first in Korea to run its own research institute it also invested a huge portion of its resources in nurturing and training research manpower.
    Chong Kun Dang Research Institute is characterized by three independent laboratories: The New Drug Discovery Labs, for identifying innovative drug candidates, The Technology Development Labs, dedicated to generic drugs,
    APIs, and botanical drugs, and the Bio Research Labs for developing antibodies, vaccines, and recombinant proteins. 
    Chong Kun Dang was able to stand as one of the top local pharmaceutical companies with distinguished achievements in drug development including the following.

    R&D Vision & Strategy

    “Better Life through Better Medicine”

    • Platform
      Technology

    • Focus on medical
      unmet needs

    • Globalization

    • New Drug

      Raising competitiveness in the
      global market

      • - Open Innovation
      • - New drug discovery through platform
          target HDAC6
          (Immunology, Neurology, Oncology)

    • Bio research center

      Securing new growth engine

      • - Infrastructure of Bio GMP manufacturing
          technology
      • - Export of biosimilars to global market
      • - Development of new biological drugs

    • Technology development
      center

      Creating sustainable growth engine

      • - Expansion of IMD pipeline
      • - Overseas expansion through platform
          technology utilization of Liquistal®
          technology

    R&D Expenditure